Use of 99mTc-sestamibi scintigraphy in multiple myeloma [5]

Journal of Nuclear Medicine

Volumn 47, Issue 3, 2006, Pages 555-

  Pace, Leonardo ^a   Salvatore, Marco ^a   Del Vecchio, Silvana ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FOLLOW UP; HUMAN; LETTER; MULTIDRUG RESISTANCE; MULTIPLE MYELOMA; PRIORITY JOURNAL; BONE TUMOR; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; IMAGE ENHANCEMENT; IMAGE SUBTRACTION; METASTASIS; METHODOLOGY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BONE NEOPLASMS; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; PHYSICIAN'S PRACTICE PATTERNS; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33645974900     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med. 2005;46:1356-1367.
2. Pace L, Catalano L, Pinto AM, et al. Different patterns of technetium-99m sestamibi uptake in multiple myeloma. Eur J Nucl Med. 1998;25:714-720.
3. Catalano L, Pace L, Califano C, et al. Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy. Haematologica. 1999;84:119-124.
4. Pace L, Catalano L, Del Vecchio S, et al. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up. Eur J Nucl Med. 2001;28:304-312.
5. Balleari E, Villa G, Garre S, et al. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease. Haematologica. 2001;86:78-84.
6. Svaldi M, Tappa C, Gebert U, et al. Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy and autologous stem cell transplantation. Ann Hematol. 2001;80:393-397.
7. Alexandrakis MG, Kyriakou DS, Passam F, Koukouraki S, Karkavitsas N. Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m-ethylene diphosphonate. Ann Hematol. 2001;80:349-353.
8. 99mTc-MIBI scan in patients with multiple myeloma. Cancer Biother Radiopharm. 2004;19:165-170.
9. 99mTc- sestamibi in predicting response to chemotherapy in patients with multiple myeloma. Q J Nucl Med. 2005;49:281-285.